Supported by: Sandesh Gulhane*, Douglas Ross*, Alexander Stewart*, Edward Mountain*, Meghan Gallacher*, Brian Whittle*, Liam Kerr*, Annie Wells*, Jeremy Balfour*, Colin Beattie*, Craig Hoy*, Miles Briggs*, Tim Eagle*, Kenneth Gibson*, Stuart McMillan* *S6M-18887 Pauline McNeill: Scotland yet to Fund Bedrolite for Children with Severe Intractable Epilepsy—That the Parliament believes that Bedrolite is a highly effective drug which is used to successfully treat severe intractable epilepsy in children who have proven unresponsive to the range of other drugs available for the condition; understands that Bedrolite is legal to use in the UK but not licensed by the relevant regulatory bodies, and for this reason it is not routinely funded through the NHS; further understands that exceptions have been made in both England and Northern Ireland to enable the NHS to meet the costs of the medicine for a small number of families; understands with concern that no case has yet been funded by the NHS in Scotland, leaving families to face hardship due to the costs of the medicine; considers that Bedrolite has very real impacts on the lives of those children who respond well to the medicine when all other options have proven ineffective, which can mean that a child can go from having hundreds of Wednesday 17 September 2025 26...